Global Enteral Feeding Formula Market By Category (Adults and Paediatrics), By Form (Powder, Liquid and Others) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast; 2023-2032
- Published date: May 2023
- Report ID: 32817
- Number of Pages: 248
The size of the Enteral Feeding Formula Market is valued at USD 5.2 billion in 2022. It is anticipated to grow at a CAGR of 7.48% from 2023-2032. It is expected to reach USD 12.36 billion in the forecast period.
The rising prevalence of diabetes patients is driving the market growth for diabetic disease-specific formula, which is created to fulfill the nutritional needs of certain patient populations.
Enteral nutrition formulations are being developed to meet the nutritional requirements of specific patient groups. For instance, formulas containing higher levels of omega-3 fatty acids are being developed to help prevent inflammation and improve neurological development in premature infants. Additionally, formulas containing more elevated amounts of fiber and complex carbohydrates are being developed to help manage blood sugar levels in patients with diabetes.
Furthermore, formulations containing higher levels of antioxidants and vitamins are being developed to help reduce the risk of cancer and chronic liver disease. Overall, the increasing prevalence of chronic liver diseases, the rising number of premature births, and expanding home care and nursing homes are all expected to drive the demand for enteral nutrition formulas in the near future.
Global Enteral Feeding Formula Market Analysis
Based on Category, the market is segmented into Adults and Pediatrics. The Adults and Pediatrics categories of the enteral feeding formula market can be further subdivided. The adult market segment is the largest segment of the enteral nutrition market, primarily due to the increasing prevalence of chronic conditions and the aging population.
According to the World Health Organization (WHO), by 2030, more than 16% of the population will be over the age of 60 years and more prone to chronic disorders such as liver failure, pulmonary disease, diabetes, and kidney failure. Enteral nutrition provides essential nutrients to help recover and manage the symptoms of diseases.
Additionally, the aged population is more likely to be prescribed enteral nutrition to supplement their diets and provide them with other essential nutrients, which is why the adult market segment has a significant market share in the enteral nutrition market.
Based on the form type, the market is segmented into powder, liquid, and other types. The liquid segment, which dominated the market in 2022, is also expected to grow at the fastest rate, with a CAGR of 7.8%. Enteral liquid feeding is a form of nutrition where a liquid formula provides nutrients to a patient. The formula comprises proteins, carbohydrates, fats, vitamins, minerals, and other essential nutrients.
Liquid formulations are easy to absorb, making them a more efficient way to provide nutrition than solid foods. They also do not clog tubes, making them the preferred method for patients who rely on enteral (gut) nutrition. Studies have shown that adding common enteral liquid feeding formulas to a pre-administered LMP solution can effectively prevent gastroesophageal reflux in severe Percutaneous endoscopic gastrostomy (PEG) patients. PEG patients may suffer from recurrent gastroesophageal reflux events, which can cause discomfort and poor nutrition.
Adding an enteral liquid feeding formula to the LMP solution can reduce the reflux events because the liquid formula helps to coat the stomach and esophagus, reducing the amount of stomach acid that can enter the esophagus. The enteral liquid feeding formula also helps provide the patient with essential nutrients they may not be able to get from a solid diet, which helps improve the patient’s overall health.
Key Market Segments
- Jejunal Tube Feeding
- Gastric Tube Feeding
- Nasogastric Tube Feeding
- Gastrostomy Tube Feeding
Increasing incidence of cancer:
Enteral nutritional formulas are a form of nutrition used to provide essential nutrients to individuals with cancer or other diseases that make it difficult for them to eat or digest food. These formulas, which can be taken orally or through a feeding tube, are designed to provide the necessary nutrition for individuals who cannot get proper nutrition from regular food or cannot take in enough calories and nutrients from regular food alone.
Enteral nutrition is becoming more popular due to the increasing number of cancer patients who need nutritional support. As cancer cases continue to rise, the demand for enteral nutrition will also increase. Additionally, enteral nutrition has been found to reduce the risk of infection in cancer patients and other complications associated with chemotherapy, radiation, and surgery. This has led to more physicians prescribing enteral nutrition to their patients.
The rise in cancer patients has also increased the demand for enteral formulas containing specialized ingredients. For example, some formulas are designed to provide the necessary nutrition for individuals undergoing chemotherapy or radiation therapy, while others are designed to provide essential nutrients to individuals with weakened immune systems. Furthermore, the market for enteral nutrition formulas is expected to be further boosted by new developments in the field.
Increased prevalence of diabetes:
The increasing prevalence of diabetes is driving the growth of the enteral feeding formula market. As the elderly population continues to rise, the need for enteral feeding formulas has also increased. This is because many elderly patients with type-2 diabetes are at increased risk for microvascular and microvascular complications. To maintain glycemic control, many patients require an enteral feeding formula to supplement their nutrition when oral feeding is inadequate.
Along with the aging population, the increasing prevalence of diabetes also contributes to the market’s growth. Unhealthy lifestyles, such as having a poor diet, have been linked to the rising incidence of diabetes, further driving the demand for enteral feeding formulas.
Additionally, one of the primary drivers of regional development is the rise in preterm births in Asian nations. These are some of the major factors propelling the market growth.
Clogging of Enteral Tubes:
When large amounts of enteral food, fillers, and medications are administered via comparatively tiny PEG tubes, it frequently results in blockages. Enteral feeding tubes are used in many medical settings to deliver nutrition to individuals who cannot eat or drink independently. These tubes are inserted through the nose or mouth and are designed to deliver nutrition directly to the stomach or small intestine.
Although enteral feeding tubes are a reliable and efficient way to provide nutrition to patients, they can be prone to obstruction or blockages. Blockages may occur when too thick foods or medications are administered through relatively small feeding tubes.
Additionally, gastric juice can coagulate and clog the tube due to its low pH value. If a blockage is not identified and cleared promptly, it can lead to serious medical issues such as undernutrition or even death. To prevent blockages or obstructions, it is important to be mindful of the type and consistency of food administered through the feeding tube.
Additionally, radiographic confirmation is an effective and reliable way to determine the existence of a blockage, but it increases the cost of care and exposes the patient to additional radiation. It is also important to avoid repeated gastric aspirations as this can lead to blockages.
The enteral nutrition market can be segmented geographically into North America, Europe, Asia-Pacific, South America, and Middle-East & Africa. In 2022, North America held a dominant market share of 35%, largely attributed to the increasing burden of chronic diseases such as diabetes, cancer, and other neurological disorders. In addition, the frequency of premature births has increased in the region, and according to the Center for Disease Prevention and Control (SPKC) data, the number of premature births will increase by 4% by 2021.
However, Asia Pacific is expected to be the fastest-growing segment due to the increasing prevalence of diabetes and cancer in the region. In addition, Asia’s population is aging faster than any other region in the world. According to a report by the Census Bureau, the number of older people in Asia is expected to nearly triple in the next four decades.
Key Regions and Countries Covered in this Report:
- North America
- The US
- The UK
- Rest of Europe
- South Korea
- Rest of Asia-Pacific
- South America
- Rest of South America
- South Africa
- Rest of MEA
Product launches, mergers and acquisitions, joint ventures, and geographical expansion are the primary strategies employed by the enteral formula industry players. The top 10 companies in the enteral milk formula market are:
Market Key Players:
- Nestle SA
- Danone SA
- Abbott Laboratories
- Mead Johnson & Company, LLC
- Hormel Foods Corporation
- Braun Melsungen AG
- Meiji Holdings Co., Ltd
- Medline Industries, Inc
- Medtrition, Inc.
- Victus, Inc.
- Other Key Players
- Primavera Capital Group (Primavera) announced in June 2021 that it had reached an agreement with Reckitt Benckiser Group plc to acquire Mead Johnson Nutrition Company (Mead Johnson), a world leader in infant formula and nutrition.
- As part of their ongoing mission to develop cutting-edge nutritional solutions, Chicago start-up Genuine Food was acquired by Nutricia, a nutrition company owned by yogurt behemoth Danone SA, in October 2020. Nutricia is dedicated to broadening the Real Food Blends mission and product portfolio to benefit youngsters and the geriatric population who use feeding tubes.
- Real Food Blends, a company based in Chesterton, Indiana, which creates real food meals for people using feeding tubes, was purchased by Nutricia in October 2020. Danone SA is a major player worldwide in the food, beverage, and nutrition industries.
Frequently Asked Questions (FAQ)List the segments encompassed in this report on the Enteral Feeding Formulas market?
Market.US has segmented the Enteral Feeding Formulas market by geographic (North America, Europe, APAC, South America, and Middle East and Africa). By Product Type, market has been segmented into Disease-specific Formulas and Standard Formula. By Flow, the market has been further divided into Intermittent Feeding Flow and Continuous Feeding Flow. By Stage, the market has been further divided into Adults and Kids. By End-Use, the market has been divided into Homecare and Hospitals.List the key industry players of the Enteral Feeding Formulas market?
Abbott, Danone SA, Fresenius Kabi, Nestlé, Victus, Inc., Primus Pharmaceuticals, Inc., Meiji Holdings. Co., Ltd., Rickett Benckiser Group Plc., and Other Key Players are the key vendors in the Enteral Feeding Formulas market engaged in the Enteral Feeding Formulas market.Which region is more appealing for vendors employed in the Enteral Feeding Formulas market?
APAC accounted for the highest revenue share of 39.8%. Therefore, the Enteral Feeding Formulas industry in APAC is expected to garner significant business opportunities over the forecast period.Name the key areas of business for Enteral Feeding Formulas?
South Korea, Germany & The US, are key areas of operation for Enteral Feeding Formulas Market.Which segment accounts for the greatest market share in the Enteral Feeding Formulas industry?
With respect to the Enteral Feeding Formulas industry, vendors can expect to leverage greater prospective business opportunities through the intermittent feeding flow type segment, as this area of interest accounts for the largest market share.What is the enteral feeding formulas market growth?
The global enteral feeding formula market is expected to grow at a compound annual growth rate of 7.48% from 2023 to 2032 to reach USD 12.36 billion by 2032.What is the Growth Rate of the Enteral Feeding Formula Market?
The Enteral Feeding Formula Market is Expected to Witness a CAGR of 7.48% During the Forecast Period of 2023 to 2032.What are the major companies operating in the Enteral Feeding Formula Market?
The major companies operating in the Enteral Feeding Formula Market are Victus, Inc., Nestlé S.A., Fresenius Kabi AG, Meiji Holdings Co. Ltd., Abbott Nutrition, Otsuka Holdings Co., Medtrition Inc., and Ajinomoto Cambrooke Inc.Which are the prominent players in the Enteral Feeding System Formula Market?
Some of the key market players in the Enteral Feeding Formula Market are Victus Inc., Nestle SA, Fresenius Kabi AG, Danone SA, Abbott Nutrition, Otsuka Holdings Co., Medtrition Inc., and Ajinomoto Cambrooke Inc.Which are the major regions in the Enteral Feeding Formula Market?
Major regions in the Enteral Feeding Formula Market are North America, Latin America, Asia Pacific, South Korea, South America, South Africa, and Saudi Arabia.
| Single User|
USD / per unit
| Multi User|
USD / per unit
| Corporate User|
USD / per unit
|Report Library Access|
|Data Set (Excel)|
|Company Profile Library Access|
|Free Custumization||No||up to 10 hrs work||up to 30 hrs work|
|Accessibility||1 User||2-5 User||Unlimited|
|Analyst Support||up to 20 hrs||up to 40 hrs||up to 50 hrs|
|Benefit||Up to 20% off on next purchase||Up to 25% off on next purchase||Up to 30% off on next purchase|
|Buy Now ($ 3,499)||Buy Now ($ 4,299)||Buy Now ($ 4,999)|